Drug-induced optic neuropathies

Drugs of Today

Volumn 43, Issue 11, 2007, Pages 827-836

  Lloyd, Michael J ^a   Fraunfelder, Frederick W ^a  

^a CASEY EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOHEXAMIDE; ACETOPHENAZINE; ALDOSTERONE; ALLOBARBITAL; AMIODARONE; AMITRIPTYLINE; AMOBARBITAL; AMODIAQUINE; BARBITAL; BECLOMETASONE; BUTALBITAL; CARMUSTINE; CHLORAMPHENICOL; CHLOROQUINE; CISPLATIN; CLINDAMYCIN; DAPSONE; DEFEROXAMINE; DIDANOSINE; DIGITALIS; ETHAMBUTOL; ETHYLENE GLYCOL; ISONIAZID; LINEZOLID; PHENAZONE; SECBUTABARBITAL; SILDENAFIL; TADALAFIL; UNINDEXED DRUG; VARDENAFIL;

DISEASE CLASSIFICATION; ENTEROCOCCAL INFECTION; GENETIC DISORDER; HEART ATRIUM FIBRILLATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIC OPTIC NEUROPATHY; KERATOPATHY; LIPIDOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OPTIC NERVE ATROPHY; OPTIC NERVE DISEASE; OPTIC NERVE LESION; OPTIC NEURITIS; PAPILLEDEMA; PERIPHERAL NEUROPATHY; PHYSICIAN; RETROBULBAR OPTIC NEUROPATHY; REVIEW; RISK ASSESSMENT; SEXUAL DYSFUNCTION; SINGLE DRUG DOSE; STAPHYLOCOCCUS INFECTION; SUBCAPSULAR CATARACT; TUBERCULOSIS; VISION; VISUAL IMPAIRMENT; VORTEX KERATOPATHY; WORLD HEALTH ORGANIZATION;

ACETAMIDES; ADVERSE DRUG REACTION REPORTING SYSTEMS; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ANTI-INFECTIVE AGENTS; ANTITUBERCULAR AGENTS; DIAGNOSIS, DIFFERENTIAL; ETHAMBUTOL; HUMANS; OPTIC NERVE DISEASES; OXAZOLIDINONES; PHARMACEUTICAL PREPARATIONS; PHOSPHODIESTERASE INHIBITORS;

EID: 38349075390     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2007.43.11.1157621     Document Type: Review

References (45)

1. Kerrison, J.B. Optic neuropathies caused by toxins and adverse drug reactions. Ophthalmol Clin N Am 2004, 17(3): 481-8.
2. Sadun, A.A. Acquired mitochondrial impairment as a cause of optic nerve disease. Trans Am Ophthalmol Soc 1998, 96: 881-923.
3. Rizzo, J.F., III. Adenosine triphosphate deficiency: a genre of optic neuropathy. Neurology 1995, 45(1): 11-6.
4. Carelli, V. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem Int 2002, 40(6): 573-84.
5. Zoumalan, C.I., Agarwal, M., Sadun, A.A. Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy. Graefe's Arch Clin Exp Ophthalmol 2005, 243: 410-6.
6. Saadati, H.G., Hsu, H.Y., Heller, K.B., Sadun, A.A. A histopathologic and morphometric differentiation of nerves in optic nerve hypoplasia and Leber's hereditary optic neuropathy. Arch Ophthalmol 1998, 116(7): 911-6.
7. Sadun, A.A. Mitochondrial optic neuropathies. J Neurol Neurosurg Psychiatry 2002, 72(4): 423-5.
8. Heng, J.E., Vorwerck, C.K., Lessell, S., Zurakowski, D., Levin, L.A., Dreyer, E.B. Ethambutol is toxic to retinal ganglion cells via an excitotoxic pathway. Invest Ophthalmol Vis Sci 1999, 40(1): 190-6.
9. Hayreh, S.S. Erectile dysfunction drugs and non-arteritic ischemic optic neuropathy: is there a cause and effect relationship? J Neuroophthalmol 2005, 25(4): 295-8.
10. Edwards I.R., Biriell, C. Harmonisation in pharmacovigilance. Drug Saf 1994, 10(2): 93-102.
11. Brick, D.C. Medication errors result in costly claims for ophthalmologists. Surv Ophthalmol 1995, 40(3): 232-6.
12. Moorthy, R.S., Valluri, S. Ocular toxicity associated with systemic drug therapy. Curr Opin Ophthalmol 1999, 10(6): 438-46.
13. Costa-Jussà F.R., Jacobs J.M. The pathology of amiodarone neurotoxicity. I. Experimental studies with reference to changes in other tissues. Brain 1985, 108 (Pt. 3): 735-52.
14. Jacobs J.M., Costa-Jussa F.R. The pathology of amiodarone neurotoxicity. II. Peripheral neuropathy in man. Brain 1985, 108(Pt 3): 753-69.
15. Besser, R., Treese, N., Bohl, J., Goebel, H.H. Clinical neurophysiology and biopsy findings in neurotoxic amiodarone syndrome. Med Klin 1994, 89(7): 367-72.
16. Macaluso, D.C., Shults, W.T., Fraunfelder, F.T. Features of amiodarone-induced optic neuropathy. Am J Ophthalmol 1999, 127(5): 610-2.
17. Hayreh, S.S. Amiodarone, erectile dysfunction drugs, and non-arteritic ischemic optic neuropathy. J Neuroophthalmol 2006, 26(1): 1-3.
18. Murphy, M.A., Murphy, J.F. Amiodarone and optic neuropathy: the heart of the matter. J Neuroophthalmol 2005, 25(3): 232-6.
19. Fraunfelder, F.W., Shults, W.T. Non-arteritic ischemic optic neuropathy, erectile dysfunction drugs, and amiodarone: is there a relationship? J Neuroophthalmol 2006, 26(1): 1-3.
20. Mindel, J.S., Anderson, J., Johnson, G., et al. Absence of bilateral vision loss from amiodarone: a randomized trial. Am Heart J 2007, 153(5): 837-42.
21. Purvin, V., Kawasaki, A., Borruat, FX. Optic neuropathy in patients using amiodarone. Arch Ophthalmol 2006, 124(5): 696-701.
22. Fraunfelder, F.T., Fraunfelder, F.W. Amiodarone. In: Drug-Induced Ocular Side Effects, 5th Ed. F.T. Fraunfelder, F.W. Fraunfelder (Eds.), Butterworth Heinemann: Boston 2000, 273-8.
23. Ghosh, M., McCulloch, C. Amiodarone-induced ultrastructural changes in human eyes. Can J Ophthalmol 1984, 19(4): 178-86.
24. Haug, S.J., Friedman, A.H. Identification of amiodarone in corneal deposits. Am J Ophthalmol 1991, 111(4): 518-9.
25. Mansour, A.R., Pulkin, J.E., O'Grady, R. Optic nerve ultrastructure following amiodarone therapy. J Clinic Neuroophthamol 1988, 8: 231-7.
26. Younge, B.R. Amiodarone and ischemic optic neuropathy. J Neuroophthalmol 2007, 27(1): 85-6.
27. Melamud, A., Kosmorsky, G.S., Lee, M.S. Ocular ethambutol toxicity. Mayo Clin Proc 2003, 78(11):1409-11.
28. Sivakumaran, P., Harrison, A.C., Marschner, J., Martin P. Ocular toxicity from ethambutol: a review of four cases and recommended precautions. N Z Med J 1998, 111(1077):428-30.
29. Fraunfelder, F.T., Fraunfelder, F.W. Ethambutol. In: Drug-Induced Ocular Side Effects, 5th Ed. F.T. Fraunfelder, F.W. Fraunfelder (Eds.), Butterworth Heinemann: Boston 2000, 92-3.
30. Kozak, S.F., Inderlied, C.B., Hsu, H.Y., Heller, K.B., Sadun, A.A. The role of copper on ethambutol's antimicrobial action and implications for ethambutol-induced optic neuropathy. Diagn Microbiol Infect Dis 1998, 30(2): 83-7.
31. Fraunfelder, F.W., Sadun, A.A., Wood, T. Update on ethambutol optic neuropathy. Expert Opin Drug Saf 2006, 5(5): 615-18.
32. Karmon, G., Savir, H., Zevin, D., Levi, J. Bilateral optic neuropathy due to combined ethambutol and isoniazid treatment. Ann Ophthalmol 1979, 11(7): 1013-17.
33. Guerra, R., Casu, L. Hydroxycobalamin for ethambutol-induced optic neuropathy. Lancet 1981, 2(8256): 1176.
34. Rucker, J.C., Hamilton, S.R., Bardenstein, D., Isada C.M., Lee, M.SI. Linezolid-associated optic neuropathy. Neurology 2006, 66(4):595-8.
35. Saijo, T., Hayashi, K., Yamada, H., Wakakura, M. Linezolid-induced optic neuropathy. Am J Ophthalmol 2005, 139(6): 114-16.
36. Javaheri, M., Khurana, R.N., O'hearn, T.M., Lai, M.M., Sadun, A.A. Linezolid-induced optic neuropathy: a mitochondrial disorder? Br J Ophthalmol 2007, 91(1): 111-15.
37. De Vriese, A.S., Coster, R.V., Smet, J., et al. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis 2006, 42(8): 1111-7.
38. Meka, V.G., Gold, H.S. Antimicrobial resistance to linezolid. Clin Infect Dis 2004, 39(7): 1010-5.
39. Lin, A.H., Murray, R.W., Vidmar, T.J., Marotti, K.R. The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin. Antimicrob Agents Chemother 1997, 41(10): 2127-31.
40. Marmor, M.F. Sildenafil (Viagra) and ophthalmology. Arch Ophthalmol 1999, 117(4): 518-9.
41. Fraunfelder, F.W. Visual side effects associated with erectile dysfunction agents. Am J Ophthalmol 2005, 140(4): 723-4.
42. Fraunfelder, F.W., Pomeranz, H.D., Egan, R.A. Nonarteritic ischemic optic neuropathy and sildenafil. Arch Ophthalmol 2006, 124(5): 733-4.
43. Margo, C.E., French, D.D. Ischemic optic neuropathy in male veterans prescribed phosphodiesterases inhibitors. Am J Ophthalmol 2007, 143(3): 538-9.
44. Gandhi, J.S. Sildenafil-associated NAION. Ophthalmology 2003, 110(9): 1860-1.
45. Hayreh, S.S., Zimmerman, M.B., Podhajsky, P, Alward, W.L. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994, 117(5): 603-24.